News: Lonza Group AG (LONN.VX)

LONN.VX on Virt-X Level 1

113.70CHF
7:13am EDT
Price Change (% chg)

CHF-0.60 (-0.52%)
Prev Close
CHF114.30
Open
CHF114.40
Day's High
CHF114.50
Day's Low
CHF113.10
Volume
58,928
Avg. Vol
184,509
52-wk High
CHF114.70
52-wk Low
CHF71.75

Search Stocks
Select another date:

Fri, Aug 22 2014

Lonza courts biotech backers to shore up outsourcing contracts

ZURICH - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.

Lonza courts biotech backers to shore up outsourcing contracts

ZURICH, Aug 22 - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.

UPDATE 2-Lonza profit boosted by drug production outsourcing

* Shares up 5.8 pct (Recasts with share price, adds analyst)

Lonza shares rise 3.3 pct after H1 results

ZURICH, July 24 - Lonza shares rise 3.3 pct at the open on Thursday after first-half net profit more than trebled. (Reporting by Joshua Franklin)

Lonza confirms full-year outlook

ZURICH, April 24 - Life science and specialty chemicals group Lonza confirmed its outlook for the full year after its business performance improved in the first quarter from the year-ago period.

Select another date:

Press Releases

Search Stocks